Cases 1 - 3 of 3
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Amgen, Inc. et al v. Hedger
as 1:2016cv03375
Plaintiff:
Amgen, Inc. and Amgen USA Inc.
Defendant:
Amy Hedger
Cause Of Action: 28 U.S.C. § 1332
Amgen Inc. et al v. Hedger
as 1:2016cv03376
Plaintiff:
Amgen USA Inc. and Amgen, Inc
Defendant:
Amy Hedger
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
